Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire October 31, 2025 MALVERN, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting […]

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire October 31, 2025 BOSTON, Oct. 31, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on October 15, 2025, the Compensation Committee of the Board of Directors granted stock options to purchase

IP Strategy Announces Reverse Stock Split

IP Strategy Announces Reverse Stock Split GlobeNewswire October 31, 2025 GIG HARBOR, Wash., Oct. 31, 2025 (GLOBE NEWSWIRE) — Heritage Distilling Holding Company Inc. d/b/a IP Strategy (Nasdaq: IPST) (the “Company”), the first company to adopt a treasury reserve policy centered on the $IP token, today announced that its Board of Directors has approved a

Cellectis to Report Third Quarter Financial Results on November 7, 2025

Cellectis to Report Third Quarter Financial Results on November 7, 2025 GlobeNewswire October 31, 2025 NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will report financial results

Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November

Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November GlobeNewswire October 31, 2025 TEL AVIV, Israel, Oct. 31, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in November as

TeraWulf Schedules Conference Call for Third Quarter 2025 Financial Results

TeraWulf Schedules Conference Call for Third Quarter 2025 Financial Results Earnings Call Set for Monday, November 10 at 4:30 p.m. ET GlobeNewswire October 31, 2025 EASTON, Md., Oct. 31, 2025 (GLOBE NEWSWIRE) — TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated, low-carbon digital infrastructure, today announced that

Edesa Biotech Announces Upcoming Conference Schedule

Edesa Biotech Announces Upcoming Conference Schedule GlobeNewswire October 31, 2025 TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that Edesa management and business development staff plan to participate in the following upcoming conferences: BIO-Europe, Vienna, Austria, November 3-5,

San Antonio Same-Sex Divorce Lawyer Linda Leeser Expands Guidance For LGBTQ+ Couples In Texas

San Antonio, TX – Linda Leeser of Family Matters Law Firm PLLC (https://myfamilymatterslaw.com/san-antonio-same-sex-divorce-lawyer/) unveils an expanded set of services and resources tailored to same-sex couples, addressing the full life cycle of marriage dissolution from property division to parentage and support. The initiative centers on practical representation for those seeking a San Antonio same-sex divorce lawyer,

SuperX Reports Annual Financial Results for FY2025; Sets Stage for AI Infrastructure Growth in FY2026

FY2025 Results Reflect Legacy Operations; Major Post-Year-End Milestones Lay Foundation for Next-Phase Expansion SuperX AI Technology Limited (NASDAQ: SUPX) (“SuperX” or “the Company”), formerly Super X AI Technology Limited and Junee Limited, today announced its financial results for the fiscal year ended June 30, 2025. FY2025 represented a pivotal year of transformation as the Company

Scroll to Top